Browse our collection of papers in
Johnson & Johnson

Select number of records per page:  

S/F/288. Financial report on GlaxoSmithKline

WORDS:
1500
DATE:
2011
PRICE:
19.99 GBP

The paper presents financial analysis of GlaxoSmithKline (GSK) for 2006-2009 describing the profile of the company, reporting on their financial performance during 2009, and conducting analysis of their financial ratios for 2006-2008. GSK performance is compared to that of Johnson & Johnson (J&J), the main competitor of GSK, suggesting investment in GSK.

 

KEYWORDS: Financial report, GlaxoSmithKline, GSK, Johnson & Johnson, J&J,

 

C/B/3130. Role of information systems in organisational change: case study of Johnson & Johnson

WORDS:
1950
DATE:
2010
PRICE:
19.99 GBP

The paper examines the role of information technology (IT) innovations in organizational change (OC) explaining the OC concept and conducting a case study of information systems (IS) implementation at Johnson & Johnson (J&J). J&J background and IT infrastructure are described, their strategies towards investment in IT are analysed.

 

KEYWORDS: Johnson & Johnson, J&J, Organisation Change, Information Systems, IS, IT innovation,

 

C/C/231. Evaluation of the link between information systems and organisational change: case study Johnson & Johnson group

WORDS:
1950
DATE:
2010
PRICE:
19.99 GBP

This paper examines the connection between organisational change and information systems (IS) looking at Johnson & Johnson Group (J&J), aiming to examine how companies use IS to handle organisational change. The paper starts by examining the notion of organisational change, followed by an overview of J&J. The IT infrastructure of J&J is discussed, explaining how the company set their IT standards. The funding of IS and the creating of data structures is evaluated, and the paper concludes by discussing the way in which IS links to organisational change.

 

KEYWORDS: Organisational change, information systems, IS, Johnson & Johnson group, IT infrastructure, data structures,

 

C/B/2192. Company Strategies in Pharmaceutical Industry: Ansoff Analysis of Johnson & Johnson, Pfizer and Merck

WORDS:
1500
DATE:
2010
PRICE:
19.99 GBP

The paper examines strategic directions in the development of three pharmaceutical companies, Johnson & Johnson (J&J), Pfizer and Merck describing the current situation within the industry and conducting comparative analysis of the companies’ products and markets using Ansoff matrix.

 

KEYWORDS: Pharmaceutical Industry, Ansoff Matrix, Johnson & Johnson, J&J, Pfizer, Merck,

 

C/B/2157. Strategic Direction of Pharmaceutical and Biotechnological Companies

WORDS:
2200
DATE:
2010
PRICE:
29.99 GBP

The paper looks at the ongoing changes in the pharmaceutical (pharma) and biotechnological (biotech) industries addressing the challenges facing pharma and biotech companies, i.e. the safety and quality of their products, the pricing of medicines, and the need to engage in profitable commercial relations. Competitive strategies of Johnson & Johnson (J&J), Merck and Pfizer are described, key competences and capabilities of J&J are identified.

 

KEYWORDS: Pharmaceutical, biotechnological, medicines, Johnson & Johnson, J&J, Merck and Pfizer,

 

C/B/2156. Using Johnson & Johnson, Pfizer and Merck, identify the strategic direction, which each has chosen, from their websites and other sources. Using appropriate models and theory compare and contrast their strategies and judge which are most likely to succeed in the future. Identify the key competences, capabilities and resources held by 'one' of the companies chosen for the first part of this assignment. How well equipped is it to meet future challenges?

WORDS:
2200
DATE:
2010
PRICE:
29.99 GBP

The paper looks at the ongoing changes in the pharmaceutical (pharma) and biotechnological (biotech) industries addressing the challenges facing pharma and biotech companies, i.e. the safety and quality of their products, the pricing of medicines, and the need to engage in profitable commercial relations. Competitive strategies of Johnson & Johnson (J&J), Merck and Pfizer are described, key competences and capabilities of J&J are identified.

 

KEYWORDS: Pharmaceutical, biotechnological, medicines, Johnson & Johnson, J&J, Merck and Pfizer,

 

C/B/2095. Strategic Vision and Mission of Johnson & Johnson

WORDS:
1100
DATE:
2010
PRICE:
19.99 GBP

The paper looks at the performance of Johnson & Johnson (J&J) in the pharmaceutical industry from the perspective of their strategic management considering the company’s strategic vision and mission statement. J&J’s policy towards life-saving and life-enhancing drugs is discussed.

 

KEYWORDS: Strategic Vision, Mission, Johnson & Johnson, J&J, pharmaceutical industry,

 

C/B/1796. Business Ethics in Johnson and Johnson

WORDS:
1600
DATE:
2009
PRICE:
19.99 GBP

The paper examines ethical dilemmas faced by Johnson and Johnson due to the Tylenol pain-killer crisis when the company sacrificed their profits by removing the drug from market shelves. Stakeholder and Kant’s theory of ethics is reviewed providing strategic suggestions about solutions to the problems faced by the organisation.

 

KEYWORDS: Johnson and Johnson, Stakeholder Theory, Ethical Dilemma, Tylenol pain killer,

 

C/F/416. Financial Performance Analysis: GSK vs. Johnson and Johnson

WORDS:
2600
DATE:
2009
PRICE:
29.99 GBP

This report looks at Financial Structure of two pharmaceutical companies i.e. GlaxoSmithKline and Johnson & Johnson. It examines the fiscal fitness of the company with the help of different financial ratios for 2003-2007 years. For each company five year financial data has been analyzed to check the overall performance of the company. Moving forward to check the corporate responsibility, share performance of the company has been diagnosed by way of dividend and earnings per share. Finally, financial performance of both the companies is compared to each other.

 

KEYWORDS: f, financial, performance, analysis, gsk, vs, johnson, johnson,

 

C/B/450. Company Analysis: Johnson & Johnson (J&J)

WORDS:
2100
DATE:
2006
PRICE:
29.99 GBP

This paper examines the dynamics of the competitive environment that characterizes Johnson & Johnson, the world's largest and most comprehensive manufacturer of health care products and associated services. The environmental analysis based on the PESTEL framework is followed by Porter's five forces framework. This leads on to SWOT analysis of the company. Opportunities and threats that are likely to impact strategic decisions and the outcomes of such decisions are also put in perspective.

 

KEYWORDS: Johnson & Johnson (J&J), PESTEL, SWOT, Porter,

 

S/B/53. Strategic analysis of pharmaceutical industry - Johnson & Johnson

WORDS:
5500
DATE:
2004
PRICE:
59.99 GBP

This report will begin from using PEST analysis and Five Forces Model to analyse the most significant business environment changes in the global pharmaceutical industry over the past decade and find out industrial trends as well as threats and opportunities for global key players. And then some main strategic responses to these external changes of current pharmaceutical industry, Johnson & Johnson will be cited as an example analyzed in details about how have the company changed in recent years and evaluate the appropriateness of the strategies to the changing circumstances in the industry. Finally, the recommendation and conclusion will be given in terms of how to follow future industrial changes.

 

KEYWORDS: strategic, pharmaceutical, industry, -, johnson, johnson,